Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-38518168 versus placebo in active rheumatoid arthritis despite methotrexate
NL-OMON33287Phase 2Not yet recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of toreforant in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Planned start Sep 2009; status: not yet recruiting.
02
Drugs
toreforant
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON33287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33287.